The immune response to foot-and-mouth disease virus (FMDV) elicited by infection or immunization with inactivated virus in adult mice was examined. A model of adoptive transfer of immunocompetent cells was used for this purpose. The results presented here indicate that both short-and long-term secondary immune responses elicited by high doses of inactivated virus are indistinguishable, at the humoral or cellular level, from that observed after infection. The responses to inactivated or infectious virus were both efficiently mediated by B cells. However, immunization with low doses of inactivated virus induced a response which, although effective in aborting infection, was fully dependent on FMDV-specific T cell cooperation. These findings suggest that the different immune responses observed after infection and immunization are mainly the result of the different viral mass presented to the immune system in each case.
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Foot-and-mouth disease virus (FMDV), the only member of the aphthovirus genus within the Picornaviridae family (Bachrach, 1977) , causes an economically important disease affecting cloven-hoofed animals (Cottral et al., 1975) . In contrast to natural infection, current FMDV vaccines prepared with inactivated virus and adjuvants elicit short-lived protection (Morgan et aL, 1980) . Some of the possible explanations, as yet unsupported by experimental data, could be a constant antigenic boosting due to virus persistence in infected animals (Gebauer et ai., 1988; our unpublished data) , the induction of more efficient immune mechanisms after infection (Lopez et al., 1990 ) or quantitative differences due to variation in the mass of virus presented to the immune system after infection or vaccination. The objective of this research was to evaluate the last possibility by characterizing the humoral and cellular immune responses of adult mice to infection and different doses of inactivated FMDV.
The neutralizing antibody response up to 120 days post-infection (p.i.) after intraperitoneal (i.p.) immunization with different amounts of inactivated FMDV (0-1, 0.5, 1 or 10 ~tg) without adjuvant is shown in Fig. 1 . Antibody titres were measured by using the constant serum/variable virus method on suckling mice (Cunha et al., 1957) . Infection of mice was carried out by i.p. inoculation of 104 suckling mouse 50% lethal doses (SMLDso) of FMDV subtype O1 Campos (O1C) diluted in 0-5 ml of PBS per mouse. FMDV was inactivated with binary ethylenimine, according to Bahnemann (1975) and virus purification was performed as described by Bachrach et al. (1964) . Mice were immunized by i.p. inoculation of inactivated virus in PBS. The duration and magnitude of the immune response correlates directly with the mass of inactivated virus used for vaccination. Thus, animals which received 0.1 ~tg of inactivated virus developed transitory and low titres of neutralizing antibodies. Immunization with less than 0-1 ~tg (0.075, 0.025 and 0-01 ~tg; data not shown) demonstrated that 0.1 ~tg was the minimum dose capable of eliciting a reproducible response in this particular system. A clear difference was obtained when 0.5 or 1 ~tg of inactivated virus was used for immunization. Interestingly, the titres of neutralizing antibody and the maintenance of antibody titres in animals which received 10 ~tg of inactivated virus were not significantly different from those observed after inoculation with infectious virus. The dose-response relationship of these results is in agreement with the results of Rweyemamu et al. (1984) obtained in cattle.
To gain insight into the cellular mechanisms mediating these antibody responses, an experimental model of adoptive transfer of immunocompetent cells was utilized (Borca et al., 1986) . Recipient mice were irradiated with 580 rad 24 h prior to FMDV infection and 107 spleen cells from mice infected 8 days previously or from virusimmunized donors were transferred by i.p. inoculation 24 h after infection. Spleen cells were o b t a i n e d by gently homogenizing the organ in 199 m e d i u m (Gibco) containing 5% foetal calf serum. Erythrocytes were lysed with T r i s -N H , C1 p H 7.2 a n d adherent cells were removed by i n c u b a t i o n for 1 h at 37 °C (5% CO2 atmosphere). T cells and B cells were purified from the n o n -a d h e r e n t cells by i n c u b a t i o n for 1 h at 37 °C with r a b b i t anti-mouse Ig serum or a n t i -T h y 1.2 m o n o c l o n a l a n t i b o d y (MAb), respectively, in the presence of guinea-pig complement. The purity of T-a n d B-enriched populations was assessed by direct immunofluorescence using fluorescein isothiocyanate-labelled a n t i -T h y 1.2 M A b a n d antimouse Ig. Only cell preparations showing more t h a n 97 % purity were used. V i r a e m i a was d e t e r m i n e d by intramuscular inoculation of a litter of six 6-day-old suckling mice with 0.05 ml of blood o b t a i n e d from two reconstituted animals each day, diluted 1/10 in PBS. Results are expressed as positive (at least one out of six mice died) or negative (no mice died). As can be seen in Table 1 , no significant difference in either the production of neutralizing a n t i b o d y or the e l i m i n a t i o n of infection was observed for animals which received cells 8 days after sensitization from donors which were either infected or were i m m u n i z e d with 10 ~tg of inactivated virus. I n both cases, repopulation of recipients with u n f r a c t i o n a t e d spleen cells or purified B cells was equally effective in eliciting the production of neutralizing a n t i b o d y a n d e l i m i n a t i o n of viraemia. Similar results were observed w h e n the donor cells were o b t a i n e d from a n i m a l s infected or i m m u n i z e d with 10 Ixg of inactivated virus 120 days earlier (Table 2) .
Both experiments show that there is a direct correlation between the ability of transferred B cells a n d ( Table 1 ). To determine whether this was due to the absence of T cells, mice were reconstituted with purified B cells and different proportions of T cells. The addition of T lymphocytes to the cell suspension used for repopulation reduced the period of viraemia to a degree which correlated directly with the proportion of T ceils present. When equal amounts of T cells and B cells were used (5 x 106 T cells plus 5 x 106 B cells), viraemia became undetectable at the same time post-reconstitution as observed for animals repopulated with untreated cells obtained from infected animals (Fig. 2 ). This T cell-dependence in a dose-response fashion raised the question of how effective the T cells could be in amplifying the B cell response.
Purified B ceils and T cells were obtained from mice 8 days post-immunization with 0-1 p.g of purified inactivated antigen. Different quantities of B cells were-added to 5 x 106 T cells (this number ofT cells was shown to be sufficient to reduce viraemia to 6 days in the experiment described in Fig. 2 ) and the mixtures were used for repopulation. As shown in Table 3 , even the smallest number of B cells tested (5 x 105) was able to eliminate the infection. Thus, doses of B ceils 20 times lower than those shown to be insufficient to abort viraemia by themselves, are effective when T cells are present.
These data indicate that for 0.1 Ixg of inactivated virus the mechanism of virus elimination is mediated by B cells, since purified T cells were previously shown to be ineffective, but that T cells play an important role in enhancing the B cell response. Thus the quantity of B cells sensitized by immunization with 0.1 p.g of inactivated virus is insufficient to produce an effective immune response and requires amplification which is Table 3 ) to a secondary one (groups 5, 6 and 8, Table 3 ). This fact could indicate that even at a very low frequency FMDV B precursor cells are effective in eliminating the infection if FMDVsensitized T cells are present. The analysis of T celldependence of the secondary response to 0.1 Ixg of inactivated virus was extended to determine whether this event requires T cells and B cells to be sensitized by the same antigen (FMDV-specific response) or whether it could be mediated by soluble factors released by T cells sensitized by an unrelated T cell-dependent antigen (KLH). As can be seen in Table 3 , T cells sensitized to KLH did not drastically modify the neutralizing antibody response observed in mice reconstituted with purified B cells from animals immunized with 0.1 Ixg of inactivated FMDV, suggesting that the dependence is virus-specific. The need for T cell collaboration observed when low doses of inactivated virus are used can be compared to those results obtained in an in vitro system by Collen et al. (1989) .
Short communication
In summary, we have shown that there does not seem to be any difference in the immune response elicited by experimental infection or by immunization with high doses of inactivated FMDV, both being relatively T cellindependent. On the other hand, the response to infection mediated by cells sensitized to low doses of inactivated FMDV is efficient only when T cells are specifically sensitized. These T cells can in turn help B cells to eliminate infection, even if they were not previously exposed to FMDV antigen. Although the role of T cells after infection or immunization with 10 ~tg of inactivated virus was not examined, its importance as an amplification factor can not be discounted. Unfortunately no data are available with regard to either the mass of viral antigen produced during infection of cattle or the immune response elicited in this species by the administration of massive amounts of inactivated virus. The amount of 140S fraction present in commercial vaccines is approximately 10 ~tg and the amount of viral particles produced during the FMDV infection is probably far greater than this. Under the experimental conditions presented here it seems likely that the differences observed between the immunization with inactivated virus could be due solely to the virus mass that is in contact with the immune system in either case.
